交易 Altimmune, Inc. - ALT CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.04 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Altimmune Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 6.87 | -0.03 | -0.43% | 6.90 | 7.24 | 6.81 |
Apr 17, 2024 | 7.02 | -0.57 | -7.51% | 7.59 | 7.59 | 6.99 |
Apr 16, 2024 | 7.49 | 0.19 | 2.60% | 7.30 | 7.63 | 7.21 |
Apr 15, 2024 | 7.50 | -0.33 | -4.21% | 7.83 | 7.96 | 7.29 |
Apr 12, 2024 | 7.97 | -0.20 | -2.45% | 8.17 | 8.26 | 7.72 |
Apr 11, 2024 | 8.39 | 0.41 | 5.14% | 7.98 | 8.51 | 7.92 |
Apr 10, 2024 | 7.98 | -0.02 | -0.25% | 8.00 | 8.29 | 7.94 |
Apr 9, 2024 | 8.37 | -0.14 | -1.65% | 8.51 | 8.67 | 8.08 |
Apr 8, 2024 | 8.59 | -0.38 | -4.24% | 8.97 | 9.08 | 8.51 |
Apr 5, 2024 | 9.08 | 0.35 | 4.01% | 8.73 | 9.14 | 8.59 |
Apr 4, 2024 | 8.88 | -0.43 | -4.62% | 9.31 | 9.48 | 8.83 |
Apr 3, 2024 | 9.26 | 0.08 | 0.87% | 9.18 | 9.49 | 8.78 |
Apr 2, 2024 | 9.33 | -0.39 | -4.01% | 9.72 | 9.81 | 9.18 |
Apr 1, 2024 | 10.21 | 0.04 | 0.39% | 10.17 | 10.98 | 9.84 |
Mar 28, 2024 | 10.16 | 1.22 | 13.65% | 8.94 | 10.47 | 8.54 |
Mar 27, 2024 | 8.86 | -0.35 | -3.80% | 9.21 | 9.58 | 7.86 |
Mar 26, 2024 | 8.62 | -0.07 | -0.81% | 8.69 | 9.05 | 8.57 |
Mar 25, 2024 | 8.51 | -0.54 | -5.97% | 9.05 | 9.24 | 8.49 |
Mar 22, 2024 | 9.05 | 0.18 | 2.03% | 8.87 | 9.30 | 8.86 |
Mar 21, 2024 | 9.08 | -0.26 | -2.78% | 9.34 | 9.64 | 9.00 |
Altimmune, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 9, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Altimmune Inc Earnings Release Q1 2024 Altimmune Inc Earnings ReleaseForecast(預報) -返回 - |
Wednesday, May 15, 2024 | ||
時間 (UTC) 14:00 | 國家 US
| 事件 Altimmune Inc GLP-1-Based Therapeutics Summit Altimmune Inc GLP-1-Based Therapeutics SummitForecast(預報) -返回 - |
Friday, September 27, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Altimmune Inc Annual Shareholders Meeting Altimmune Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | -0.068 | 4.41036 | 8.18503 | 5.8014 | 10.3312 |
收入 | -0.068 | 4.41036 | 8.18503 | 5.8014 | 10.3312 |
總營業費用 | 87.672 | 101.324 | 62.9838 | 27.2663 | 53.1656 |
銷售/一般/行政費用,總計 | 17.134 | 15.4133 | 13.2094 | 8.50078 | 9.76558 |
研究與開發 | 70.538 | 74.5212 | 49.7275 | 17.618 | 18.3757 |
異常費用(收入) | 0 | 11.37 | 0 | 1 | 24.9407 |
營業收入 | -87.74 | -96.914 | -54.7987 | -21.4649 | -42.8344 |
利息收入(費用),非經營淨值 | 2.862 | 0.19708 | 0.31309 | 0.87117 | -2.76442 |
其他,淨值 | -0.032 | -0.37387 | 0.02415 | 0.01514 | 0.27789 |
稅前淨收入 | -84.91 | -97.0908 | -54.4615 | -20.5786 | -45.3209 |
稅後淨收入 | -84.713 | -97.0908 | -49.0445 | -20.5201 | -39.1712 |
未計算非常項目前的淨收益 | -84.713 | -97.0908 | -49.0445 | -20.5201 | -39.1712 |
淨收入 | -84.713 | -97.0908 | -49.0445 | -20.5201 | -39.1712 |
Total Adjustments to Net Income | 0 | -0.45293 | -3.3078 | ||
普通股股東可獲收益 (不含非經常性項目) | -84.713 | -97.0908 | -49.0445 | -20.9731 | -42.479 |
普通股股東可獲收益 (含非經常性項目) | -84.713 | -97.0908 | -49.0445 | -20.9731 | -42.479 |
攤薄淨收入 | -84.713 | -97.0908 | -49.0445 | -20.9731 | -42.479 |
攤薄後加權平均股 | 46.9263 | 41.2835 | 25.637 | 13.125 | 2.80238 |
扣除特別項目的每股攤薄盈利 | -1.80523 | -2.35181 | -1.91303 | -1.59795 | -15.1582 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -1.80523 | -2.07639 | -1.91303 | -1.54843 | -9.37328 |
Depreciation / Amortization | 0.01992 | 0.04681 | 0.1475 | 0.08365 | |
非常規項目總計 | 0 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.006 | 0.021 | -0.068 | 0.002 | 0.008 |
收入 | 0.006 | 0.021 | -0.068 | 0.002 | 0.008 |
總營業費用 | 18.013 | 21.78 | 87.672 | 24.754 | 20.403 |
銷售/一般/行政費用,總計 | 4.76 | 4.531 | 17.134 | 4.492 | 4.41 |
研究與開發 | 13.253 | 17.249 | 70.538 | 20.262 | 15.993 |
營業收入 | -18.007 | -21.759 | -87.74 | -24.752 | -20.395 |
利息收入(費用),非經營淨值 | 1.833 | 1.666 | 2.862 | 0.989 | 0.263 |
其他,淨值 | 0.113 | 0.019 | -0.032 | 0.05 | 0.025 |
稅前淨收入 | -16.061 | -20.074 | -84.91 | -23.713 | -20.107 |
稅後淨收入 | -16.061 | -20.074 | -84.713 | -23.516 | -20.107 |
未計算非常項目前的淨收益 | -16.061 | -20.074 | -84.713 | -23.516 | -20.107 |
淨收入 | -16.061 | -20.074 | -84.713 | -23.516 | -20.107 |
普通股股東可獲收益 (不含非經常性項目) | -16.061 | -20.074 | -84.713 | -23.516 | -20.107 |
普通股股東可獲收益 (含非經常性項目) | -16.061 | -20.074 | -84.713 | -23.516 | -20.107 |
攤薄淨收入 | -16.061 | -20.074 | -84.713 | -23.516 | -20.107 |
攤薄後加權平均股 | 50.6916 | 50.1257 | 46.9263 | 49.2865 | 47.5026 |
扣除特別項目的每股攤薄盈利 | -0.31684 | -0.40047 | -1.80523 | -0.47713 | -0.42328 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.31684 | -0.40047 | -1.80523 | -0.47713 | -0.42328 |
異常費用(收入) | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 192.813 | 204.126 | 230.257 | 39.3947 | 39.3721 |
現金和短期投資 | 184.88 | 190.301 | 215.923 | 37.2401 | 33.7187 |
現金等價物 | 111.097 | 190.301 | 115.918 | 8.96269 | 33.7187 |
應收賬款總額,淨額 | 2.541 | 5.83848 | 12.373 | 1.65028 | 4.47091 |
應收賬款 - 貿易,淨額 | 0.173 | 0.42884 | 4.6102 | 1.02118 | 3.46194 |
預付的費用 | 5.358 | 7.95269 | 1.92668 | 0.47023 | 0.54809 |
其他流動資産,總計 | 0.034 | 0.03417 | 0.03417 | 0.03417 | 0.63442 |
總資産 | 206.928 | 218.865 | 245.115 | 54.058 | 54.7505 |
物業/廠房/設備,總計 - 淨額 | 1.677 | 2.24596 | 1.96075 | 1.80253 | 1.3428 |
物業/廠房/設備,總計 - 總額 | 3.175 | 4.29284 | 3.55956 | 3.1501 | 2.45055 |
累計折舊,總計 | -1.498 | -2.04688 | -1.59881 | -1.34757 | -1.10775 |
商譽,淨額 | |||||
無形資産,淨額 | 12.419 | 12.419 | 12.8238 | 12.7322 | 13.8519 |
其他長期資産,總計 | 0.019 | 0.0738 | 0.07341 | 0.12855 | 0.18368 |
流動負債總額 | 17.054 | 18.2759 | 12.0204 | 3.923 | 4.52741 |
應付賬款 | 4.804 | 2.03449 | 0.61229 | 0.01823 | 0.37286 |
預提費用 | 11.081 | 10.1514 | 11.3884 | 3.8432 | 4.0632 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 1.169 | 6.09 | 0.01975 | 0.06156 | 0.01975 |
負債總額 | 21.635 | 19.7301 | 19.2389 | 8.53787 | 6.43798 |
長期債務總額 | 0 | 0 | 0 | 0 | 0.50117 |
長期債務 | 0 | 0.50117 | |||
遞延所得稅 | 0.0585 | ||||
其他負債,總計 | 4.581 | 1.4542 | 7.21844 | 4.61488 | 1.3509 |
股權 | 185.293 | 199.135 | 225.876 | 45.5201 | 48.3126 |
Redeemable Preferred Stock | 0 | ||||
普通股 | 0.005 | 0.00409 | 0.0037 | 0.00151 | 0.00088 |
額外實收資本 | 568.399 | 497.342 | 417.338 | 187.915 | 170.208 |
留存收益(累計赤字) | -377.884 | -293.171 | -186.421 | -137.376 | -116.856 |
其他權益,總計 | -5.227 | -5.04016 | -5.04452 | -5.02016 | -5.04016 |
總負債和股東權益 | 206.928 | 218.865 | 245.115 | 54.058 | 54.7505 |
已發行普通股總數 | 49.1998 | 40.9938 | 37.1429 | 15.3122 | 9.07824 |
長期債務的當前部分/資本租賃 | 0 | 0.0716 | |||
短期投資 | 73.783 | 0 | 100.006 | 28.2774 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 152.964 | 169.532 | 173.111 | 192.813 | 211.004 |
現金和短期投資 | 140.779 | 159.954 | 165.729 | 184.88 | 201.827 |
現金等價物 | 86.855 | 102.352 | 104.69 | 111.097 | 127.465 |
短期投資 | 53.924 | 57.602 | 61.039 | 73.783 | 74.362 |
應收賬款總額,淨額 | 4.529 | 3.715 | 3.37 | 2.541 | 4.353 |
應收賬款 - 貿易,淨額 | 0.876 | 0.136 | 0.252 | 0.173 | 0.633 |
預付的費用 | 7.615 | 5.822 | 3.978 | 5.358 | 4.79 |
其他流動資産,總計 | 0.041 | 0.041 | 0.034 | 0.034 | 0.034 |
總資産 | 166.573 | 183.316 | 187.083 | 206.928 | 225.277 |
物業/廠房/設備,總計 - 淨額 | 1.189 | 1.366 | 1.548 | 1.677 | 1.821 |
物業/廠房/設備,總計 - 總額 | 3.175 | ||||
累計折舊,總計 | -1.498 | ||||
無形資産,淨額 | 12.419 | 12.419 | 12.419 | 12.419 | 12.419 |
其他長期資産,總計 | 0.001 | -0.001 | 0.005 | 0.019 | 0.033 |
流動負債總額 | 11.871 | 11.437 | 14.951 | 17.054 | 15.742 |
應付賬款 | 3.046 | 4.035 | 5.238 | 4.804 | 1.419 |
預提費用 | 8.825 | 7.346 | 8.544 | 11.081 | 13.154 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0 | 0.056 | 1.169 | 1.169 | 1.169 |
負債總額 | 16.176 | 15.602 | 19.351 | 21.635 | 20.248 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 4.305 | 4.165 | 4.4 | 4.581 | 4.506 |
股權 | 150.397 | 167.714 | 167.732 | 185.293 | 205.029 |
普通股 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
額外實收資本 | 590.206 | 586.908 | 570.786 | 568.399 | 566.551 |
留存收益(累計赤字) | -434.69 | -414.019 | -397.958 | -377.884 | -356.224 |
其他權益,總計 | -5.124 | -5.18 | -5.101 | -5.227 | -5.303 |
總負債和股東權益 | 166.573 | 183.316 | 187.083 | 206.928 | 225.277 |
已發行普通股總數 | 52.8589 | 52.6577 | 49.2867 | 49.1998 | 49.1616 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -84.713 | -97.0908 | -49.0445 | -20.5201 | -39.1712 |
經營活動産生的現金 | -62.586 | -78.2379 | -34.3058 | -9.602 | -9.38891 |
經營活動産生的現金 | 0.5513 | 0.42888 | 0.23982 | 0.21872 | |
Amortization | 0.1475 | 0.08365 | |||
非現金物品 | 8.016 | 18.5521 | 18.8219 | 8.76996 | 28.6495 |
Cash Taxes Paid | 0 | 0.00179 | 0 | 0.05721 | |
營運資金的變化 | 14.111 | -0.25053 | -4.51216 | 1.81936 | 6.98019 |
投資活動産生的現金 | -73.399 | 87.5231 | -72.2258 | -28.2864 | -1.00114 |
資本支出 | -0.126 | -12.3117 | -0.34242 | -0.029 | -1.01563 |
其他投資現金流量項目,總計 | -73.273 | 99.8348 | -71.8834 | -28.2574 | 0.01449 |
融資活動産生的現金 | 56.781 | 65.0978 | 213.487 | 12.5321 | 32.4899 |
融資現金流項目 | 0 | -0.11852 | 0 | ||
股票的發行(報廢),淨額 | 56.781 | 65.2163 | 213.487 | 12.8241 | 34.0396 |
債務的發行(退還),淨額 | 0 | 0 | -0.292 | -1.5497 | |
外彙效應 | -0.05037 | ||||
現金淨變化 | -79.204 | 74.383 | 106.955 | -25.3563 | 22.0495 |
Deferred Taxes | -0.0585 | -6.14979 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -20.074 | -84.713 | -63.053 | -39.537 | -19.43 |
Cash From Operating Activities | -19.407 | -62.586 | -45.28 | -30.23 | -13.526 |
Cash From Operating Activities | 0.031 | 0.172 | 0.119 | ||
Non-Cash Items | 2.301 | 8.016 | 6.112 | 4.033 | 0.143 |
Changes in Working Capital | -1.634 | 14.111 | 11.63 | 5.102 | 5.642 |
Cash From Investing Activities | 13.302 | -73.399 | -74.38 | -48.977 | -0.009 |
Capital Expenditures | -0.051 | -0.126 | -0.088 | -0.028 | -0.009 |
Other Investing Cash Flow Items, Total | 13.353 | -73.273 | -74.292 | -48.949 | 0 |
Cash From Financing Activities | -0.302 | 56.781 | 56.824 | 24.764 | 3.181 |
Financing Cash Flow Items | -0.013 | 0 | 0 | -0.036 | -0.119 |
Issuance (Retirement) of Stock, Net | -0.289 | 56.781 | 56.824 | 24.8 | 3.3 |
Net Change in Cash | -6.407 | -79.204 | -62.836 | -54.443 | -10.354 |
Cash Taxes Paid | |||||
Issuance (Retirement) of Debt, Net |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
910 Clopper Rd Ste 201S
GAITHERSBURG
MARYLAND 20878-1361
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易